Changes

Jump to: navigation, search

Erdafitinib (Balversa)

106 bytes added, 17:32, 12 May 2019
m
no edit summary
<br>Route: PO
<br>Extravasation: n/a
*Monitor for hyperphosphatemia; dose adjustments may be needed per package insert<ref name="insert"></ref>
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the package insert.<ref name="insert"></ref>
LookupUsers, editors, emailconfirmed
3,827
edits

Navigation menu